IDEAYA Biosciences（NASDAQ:IDYA）報告季度每股虧損$(1.49)，低於分析師一致預期的$(0.64)，差距為132.81%。 相比去年同期每股虧損$(0.52)，這是一個186.54%的下降。 公司報告季度銷售額為$700萬，高於分析師一致預期的$467萬，超出50.00%。相比去年同期的$392萬，銷售額增長了78.43%。

以上內容來自Benzinga Earnings專欄，原文如下：

IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(1.49) per share which missed the analyst consensus estimate of $(0.64) by 132.81 percent. This is a 186.54 percent decrease over losses of $(0.52) per share from the same period last year. The company reported quarterly sales of $7.00 million which beat the analyst consensus estimate of $4.67 million by 50.00 percent. This is a 78.43 percent increase over sales of $3.92 million the same period last year.